triazolam has been researched along with Ataxia in 5 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sleepiness, agitation and ataxia were significantly more frequent in the children." | 5.28 | Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children. ( Descotes, J; Frantz, P; Mollon, P; Pham, E; Pulce, C, 1992) |
| "Zolpidem and triazolam produced dose-dependent reductions in locomotion and environment-directed behavior and increased ataxia and procumbent posture." | 3.71 | Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. ( Cook, J; Ma, C; Platt, DM; Rowlett, JK; Spealman, RD, 2002) |
| " The peak concentration was 4." | 2.70 | Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients. ( Coldwell, SE; Kaakko, T; Kharasch, ED; Milgrom, P; Spieker, M; Tweedy, CM, 2001) |
| "Triazolam has shown promise as a sedative agent for use in pediatric dentistry." | 2.69 | A randomized clinical trial of triazolam in 3- to 5-year-olds. ( Coldwell, SE; Kaakko, T; Karl, HW; Milgrom, P; Perkis, V; Raadal, M; Weinstein, P, 1999) |
| "Sleepiness, agitation and ataxia were significantly more frequent in the children." | 1.28 | Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children. ( Descotes, J; Frantz, P; Mollon, P; Pham, E; Pulce, C, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Platt, DM | 1 |
| Rowlett, JK | 1 |
| Spealman, RD | 1 |
| Cook, J | 1 |
| Ma, C | 1 |
| Raadal, M | 1 |
| Coldwell, SE | 2 |
| Kaakko, T | 2 |
| Milgrom, P | 2 |
| Weinstein, P | 1 |
| Perkis, V | 1 |
| Karl, HW | 1 |
| Tweedy, CM | 1 |
| Kharasch, ED | 1 |
| Spieker, M | 1 |
| Wang, RI | 1 |
| Wilbur, M | 1 |
| Hieb, E | 1 |
| Pulce, C | 1 |
| Mollon, P | 1 |
| Pham, E | 1 |
| Frantz, P | 1 |
| Descotes, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Oral Anxiolysis for the Older Pediatric Patient-Which Medication is Preferred?[NCT03360123] | 4 participants (Actual) | Interventional | 2018-01-26 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for triazolam and Ataxia
| Article | Year |
|---|---|
A randomized clinical trial of triazolam in 3- to 5-year-olds.
Topics: Administration, Oral; Anesthesia, Dental; Ataxia; Behavior Therapy; Chi-Square Distribution; Child B | 1999 |
Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients.
Topics: Administration, Sublingual; Amnesia; Anti-Anxiety Agents; Area Under Curve; Ataxia; Child; Child, Pr | 2001 |
Determining optimum dose and acute tolerance of triazolam.
Topics: Adult; Anti-Anxiety Agents; Ataxia; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug | 1977 |
2 other studies available for triazolam and Ataxia
| Article | Year |
|---|---|
Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Topics: Animals; Ataxia; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Drug Interactions; F | 2002 |
Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children.
Topics: Adolescent; Age Factors; Anti-Anxiety Agents; Ataxia; Benzodiazepines; Benzodiazepinones; Child, Pre | 1992 |